STK11 and hepatocellular carcinoma: On the contrary, FBXO22 facilitated tumorigenesis and progression via regulating the ubiquitination and degradation of p21 in hepatocellular carcinoma (42), of LKB1 in lung cancer, and of nuclear PTEN in colorectal cancer (43).